These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21365202)

  • 1. Tardive dyskinesia.
    Aia PG; Revuelta GJ; Cloud LJ; Factor SA
    Curr Treat Options Neurol; 2011 Jun; 13(3):231-41. PubMed ID: 21365202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N; Jankovic J
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Tardive Dyskinesia.
    Bashir HH; Jankovic J
    Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive Dyskinesia.
    Tarsy D
    Curr Treat Options Neurol; 2000 May; 2(3):205-214. PubMed ID: 11096748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia: Who gets it and why.
    Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():151-154. PubMed ID: 30522959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
    Bhidayasiri R; Jitkritsadakul O; Friedman JH; Fahn S
    J Neurol Sci; 2018 Jun; 389():67-75. PubMed ID: 29454493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S
    Adv Neurol; 1983; 37():267-76. PubMed ID: 6858776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of tardive dyskinesia.
    Margolius A; Fernandez HH
    Parkinsonism Relat Disord; 2019 Feb; 59():155-160. PubMed ID: 30591350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of tardive dyskinesia: use of dopamine-depleting agents.
    Fahn S
    Clin Neuropharmacol; 1983 Jun; 6(2):151-8. PubMed ID: 6133619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive Dyskinesia in Older Persons Taking Antipsychotics.
    Citrome L; Isaacson SH; Larson D; Kremens D
    Neuropsychiatr Dis Treat; 2021; 17():3127-3134. PubMed ID: 34703232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.
    Ward KM; Citrome L
    Neurol Ther; 2018 Dec; 7(2):233-248. PubMed ID: 30027457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report.
    Lv L; Guo P; Feng M; Fang Y; Wang SK; Chen HX
    World J Clin Cases; 2023 Nov; 11(32):7895-7899. PubMed ID: 38073685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valbenazine for the treatment of tardive dyskinesia.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive drug-induced extrapyramidal syndromes.
    Marsálek M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():14-33. PubMed ID: 11072762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement-based Diagnosis and Treatment for Tardive Dyskinesia.
    Correll CU; Citrome L
    J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34464521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.